Himadri Speciality Chemical Lt
7,338words
126turns
13analyst exchanges
3executives
Management on call
Anurag Choudhary
CHAIRMAN, MANAGING
Kamlesh Agarwal
CHIEF FINANCIAL
Chirag Bhatiya
MUFG INTIME
Key numbers — 40 extracted
INR120 crore
100 GW
rs,
INR 1,006 crore
INR1,001 crore
INR 755 crore
1%
1,288 crore
1,135 crore
14%
280 crore
21%
Guidance — 20 items
Anurag Choudhary
opening
“Execution of Phase 1 of our lithium-ion phosphate cathode active material project, which envisages a total capacity of 40,000 metric tons per annum is on track.”
Anurag Choudhary
opening
“As part of this phased execution, the first milestone capacity of 2,000 metric tons is targeted for commissioning by Q3 FY27.”
Anurag Choudhary
opening
“The balance Phase 1 capacity will be progressively brought onstream over the subsequent 12 months, closely aligned with customer approvals and demand visibility, with FY29 envisaged as the year for full Phase 1 operations.”
Anurag Choudhary
opening
“During the year, Sicona has achieved important milestones at pilot scale level, with further capacity expansion currently underway and targeted for completion by Q2 FY27, supporting intensified engagement with global cell manufacturers across multiple stages of sample approvals.”
Anurag Choudhary
opening
“I'm pleased to report that FY26 has been a year of strong execution and delivery.”
Anurag Choudhary
opening
“FY26 marked the first half year of operations of Birla Tyres.”
Anurag Choudhary
opening
“We are now entering the next phase of revival, where production ramp-up will be aligned closely with demand visibility and channel expansion.”
Anurag Choudhary
opening
“Over the next 12 to 24 months, we will be progressively enhance our capacity utilization, supported by robust pipeline of new product launches across agriculture, mining and commercial vehicle segments.”
Anurag Choudhary
opening
“Looking ahead, our anthraquinone and carbazole project is progressing as planned and expected to commission in Q2 FY27, helping address a significant import dependency in India.”
Anurag Choudhary
opening
“As I conclude FY26 marks an important milestone in Himadri’s transformation journey.”
Risks & concerns — 3 flagged
The statements are not guarantee of the future performance and involve risks and uncertainty that are difficult to predict.
— Chirag Bhatiya
Sir, secondly, on the U.S.-Iran war and geopolitical situation, due to the commodity prices and inflation and all over the world, how do we see impacting our types of business and whether we will face any pressure going forward due to this war?
— Akshay
That -- this time we hedged the position, thinking it was going to be volatile, and that's why we had the FX loss.
— Anurag Choudhary
Q&A — 13 exchanges
Speaking time
56
15
10
8
8
7
5
4
3
3
Opening remarks
Chirag Bhatiya
Good evening, everyone, and welcome to Q4 FY '26 Earnings Conference Call of Himadri Speciality Chemicals Limited. On the call, we have with us Mr. Anurag Choudhary, CMD and CEO; and Mr. Kamlesh Agarwal, CFO. Before we proceed with the call, I would like to give you a disclaimer that this conference call may contain forward-looking statements about the company, which are based on belief, opinion and expectation as of today. Actual results may differ materially. The statements are not guarantee of the future performance and involve risks and uncertainty that are difficult to predict. A detailed safe harbor statement is being given on Page 2 of investor presentation of the company, which are being uploaded on the stock exchange and on the company website. With this, I now hand over the call to Mr. Anurag Choudhary. Over to you, sir.
Anurag Choudhary
Thank you, Chirag. Good evening, ladies and gentlemen, and thank you for joining us today to discuss Himadri Speciality Chemical Limited's performance for Q4 and FY'26. I sincerely appreciate your continued trust and engagement, and it is a pleasure to connect with you once again. At Himadri, research and development is not merely an enabler. It is foundational to who we are and how we have evolved over the years. It is not a standalone function, but deeply embedded in our business strategy and culture. It is part of Himadri's DNA. Our growth into high-value speciality chemicals and advanced materials has been driven by deep and sustainable commitment to in-house innovation, supported by a robust and constantly evolving research and development ecosystem. Today, we operate one of the India's most comprehensive speciality solutions, research and development platforms with a team of over 180 scientists, technologists and subject matter experts, including 28 PhDs in different streams of c
Kamlesh Agarwal
Thank you, Anurag ji. Good evening, everyone, and thank you for joining us today. I trust that everyone has had a chance to review our financial results and the latest investor presentation, which have been made available on both the stock exchanges and our company’s website. This quarter and year marked an important milestone in our transformation journey. On a consolidated basis, we are pleased to share that we have achieved highest EBITDA and PAT on both quarterly and full year basis, which was down to our focus on high value-added solutions, operational efficiency and cost optimization. From a quarterly perspective, in Q4 FY26, our consolidated revenue stood at INR ~1,288 crores as compared to INR ~1,135 crores an increase of 14%. EBITDA came in at INR ~280 crores, registering a growth of 21% year-on-year, while PAT stood at INR ~208 crores, delivering a strong growth of ~34% year-on-year. Looking at the cumulative performance for full year basis, our consolidated revenue stood at